126 related articles for article (PubMed ID: 2618899)
21. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced urothelial cancer].
Mikami K; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Nakao M
Hinyokika Kiyo; 1994 Apr; 40(4):303-7. PubMed ID: 8191968
[TBL] [Abstract][Full Text] [Related]
23. Cancer occurrence among dyestuff workers exposed to aromatic amines. A long term follow-up study.
Naito S; Tanaka K; Koga H; Kotoh S; Hirohata T; Kumazawa J
Cancer; 1995 Oct; 76(8):1445-52. PubMed ID: 8620422
[TBL] [Abstract][Full Text] [Related]
24. Bladder tumor incidence among workers exposed to benzidine: a thirty-year follow-up.
Meigs JW; Marrett LD; Ulrich FU; Flannery JT
J Natl Cancer Inst; 1986 Jan; 76(1):1-8. PubMed ID: 3455732
[TBL] [Abstract][Full Text] [Related]
25. Endoluminal instillation of epidoxorubicin as adjuvant treatment for upper urinary tract urothelial tumours.
Ponchietti R; Neri B; Di Loro F; Raugei A
Anticancer Res; 1996; 16(1):537-9. PubMed ID: 8615667
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study on the occupational urinary tract tumor in Wakayama (author's transl)].
Nakamura J; Takamatsu M; Doi J; Ohkawa T; Fujinaga T; Ebisuno S; Sone M
Nihon Hinyokika Gakkai Zasshi; 1980 Aug; 71(8):945-51. PubMed ID: 7431721
[No Abstract] [Full Text] [Related]
27. Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
Bi W; Rao JY; Hemstreet GP; Fang P; Asal NR; Zang M; Min KW; Ma Z; Lee E; Li G
J Occup Med; 1993 Jan; 35(1):20-7. PubMed ID: 7678643
[TBL] [Abstract][Full Text] [Related]
28. [An epidemiological study of the cancer morbidity in persons having industrial contact with carcinogenic amino compounds].
Bul'bulian MA
Vopr Onkol; 1991; 37(3):275-9. PubMed ID: 2031321
[TBL] [Abstract][Full Text] [Related]
29. [Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer].
Sella A; Flex D; Gafni D; Rabinovitz O; Sulkes A; Baniel J
Harefuah; 1999 Feb; 136(4):268-71, 340, 339. PubMed ID: 10914214
[TBL] [Abstract][Full Text] [Related]
30. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
[TBL] [Abstract][Full Text] [Related]
31. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
[TBL] [Abstract][Full Text] [Related]
32. An assessment of the effect of improved working conditions on bladder tumor incidence in a benzidine manufacturing facility.
Ferber KH; Hill WJ; Cobb DA
Am Ind Hyg Assoc J; 1976 Jan; 37(1):61-8. PubMed ID: 1246951
[TBL] [Abstract][Full Text] [Related]
33. Bladder cancer mortality of workers exposed to aromatic amines: an updated analysis.
Piolatto G; Negri E; La Vecchia C; Pira E; Decarli A; Peto J
Br J Cancer; 1991 Mar; 63(3):457-9. PubMed ID: 2003988
[No Abstract] [Full Text] [Related]
34. [Occupational cancer of the urinary bladder: the diagnostic value of urinary cytology in dyestuff workers exposed to aromatic amines].
Matsushima M
Hinyokika Kiyo; 1989 Dec; 35(12):2033-40. PubMed ID: 2618902
[TBL] [Abstract][Full Text] [Related]
35. Clinical study on urothelial tumors of dye workers in Wakayama City.
Shinka T; Sawada Y; Morimoto S; Fujinaga T; Nakamura J; Ohkawa T
J Urol; 1991 Dec; 146(6):1504-7. PubMed ID: 1942328
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
[TBL] [Abstract][Full Text] [Related]
37. An epidemiological study of occupational bladder tumours in the dye industry of Japan.
Tsuchiya K; Okubo T; Ishizu S
Br J Ind Med; 1975 Aug; 32(3):203-9. PubMed ID: 1156568
[TBL] [Abstract][Full Text] [Related]
38. [Prophylactic intravesical chemotherapy in bladder tumors after surgery of upper tract urothelial carcinoma].
Tari K; Satake I; Kojima S; Negishi T; Yoshida K; Nakame Y; Kanaoya F; Horiuchi S; Saito T; Owada F
Hinyokika Kiyo; 1987 Jun; 33(6):852-6. PubMed ID: 3118664
[TBL] [Abstract][Full Text] [Related]
39. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic experience of advanced urothelial tract tumors.
Nakada T; Akiya T; Yoshikawa M; Umeda K; Katayama T
Hinyokika Kiyo; 1985 Apr; 31(4):601-6. PubMed ID: 4041118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
